Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cue Biopharma, Inc.

0.6952
+0.00320.46%
Post-market: 0.6703-0.0249-3.58%15:58 EDT
Volume:66.63K
Turnover:46.44K
Market Cap:52.38M
PE:-1.07
High:0.7098
Open:0.6920
Low:0.6700
Close:0.6920
Loading ...
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 25, 2023

Major Issues Report

8-K - Current report
Apr 12, 2023

Major Issues Report

8-K - Current report
Mar 21, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 21, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals